跳至主要内容
临床试验/JPRN-UMIN000036449
JPRN-UMIN000036449已完成2 期

Randomized Phase II study of adjuvant chemotherapy with GC versus GS in patients with BTC undergoing curative resection without major hepatectomy - KHBO1901

Kansai Hepatobiliary Oncology Group (KHBO)0 个研究点目标入组 106 人开始时间: 2019年4月17日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Distant metastasis except of positive CY 2) Not performed lobectomy 3) Other concurrent active cancer (synchronous double cancer or heterochronous double cancer with a disease-free interval of 3 years or shorter, excluding lesions consistent with intraepithelial cancer, i.e., intramucosal cancer that are assessed as cured by endoscopical treatment.) 4) Patients with a history of severe drug hypersensitivity or drug allergy. 5) Serious complicating disorders (Interstitial pneumonia, pulmonary fibrosis or severe emphysema, hepatic cirrhosis, uncontrollable-diabetes, cardiac disease, renal failure, liver failure, hemorrhagic peptic ulcer etc). 6) Active infection requiring systemic therapy 7) Pregnant or lactating women, women with childbearing potential, males males who wish a pregnancy of his partner. 8) Severe psychiatric disease. 9) Inappropriate for this study judged by the attending physician

研究者

发起方
Kansai Hepatobiliary Oncology Group (KHBO)

相似试验